JAÈøÆ»Áí¹çɱ¡¤Ç¤ÏÀ¸Ì¿¤Îº¤µ¤È¿Í´Ö°¦¤ò´ðÄ´¤Ë¡¢°å»Õ¡¦´Ç¸î»Õ¤È¤â¤ËÎϤò¹ç¤ï¤»¡¢É¤á¤ë¿Í¡¹¤ò¼é¤ê¡¢ÃÏ°è¤Î´ð´´É±¡¤È¤·¤Æ¤Î¼«³Ð¤ò»ý¤Á¡¢¾ï¤Ë¿·¤·¤¯¤è¤ê¹â¤¤Ãμ±¤Î½¬ÆÀ¤Èµ»½Ñ¤Î¸¦ïÓ¤ËÎå¤ß¤Þ¤¹¡£

JAÈøÆ»Áí¹çɱ¡

¥Û¡¼¥à ¡ä°åÎÅ´Ø·¸¼Ô¤ÎÊý¤Ø ¡äÃø½ñ¡¦³Ø²ñ¡¦ÏÀʸ

Ãø½ñ¡¦³Ø²ñ¡¦ÏÀʸ

ÅöÈøÆ»Áí¹çɱ¡¡¢¤ª¤è¤Ó³Æ°å»Õ¤Ë¤è¤Ã¤Æȯɽ¤µ¤ì¤¿Ãø½ñ¡¢³Ø²ñ¤Ç¤ÎȯɽÏÀʸ¤Ê¤É¤ò¸ø³«¤·¤Æ¤¤¤Þ¤¹¡£

ÈøÆ»Áí¹çɱ¡¡¦Ãø½ñ¡¦³Ø²ñ¡¦ÏÀʸ
 

[ ÉÂÍý¸¦µæ¸¡ºº²Ê ] ¤Ë¤è¤ëÃø½ñ¡¦³Ø²ñ¡¦ÏÀʸ

¡ÖÃø½ñ¡×¡Ö³Ø²ñ¡×¡ÖÏÀʸ¡×¤ÎʬÌî¤Ëʬ¤«¤ì¤Æ¤¤¤Þ¤¹¡£¤´´õ˾¤ÎʬÌî¤ò¥¯¥ê¥Ã¥¯¤¹¤ë¤È°ìÍ÷¤¬É½¼¨¤µ¤ì¤Þ¤¹¡£

¥Ç¡¼¥¿¹Ê¹þ
¥­¡¼¥ï¡¼¥É

!¹¹¿·Æü¡§2025/02/21

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë A case of coexistent poorly differentiated adenosquamous carcinoma¡Êglassy cell carcinoma¡Ë¡¤usual-type adenocarcinoma¡¤and squamous cell carcinoma in situ of the cervix
»¨»ï¥¿¥¤¥È¥ë Medical Molecular Morphology¡¤ 56¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 217-224
Ãø¼Ô Habara K
¶¦Ãø Nishikori A¡¤Kiyama J¡¤Nakashima M¡¤Koda M¡¤Sasaki K¡¤Sakashita T¡¤Tanaka N¡¤Yonehara S

!¹¹¿·Æü¡§2025/02/21

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë Hepatoid adenocarcinoma of the stomach effectively treated with capecitabine with oxaliplatin as adjuvant chemotherapy¡§A case report and literature review
»¨»ï¥¿¥¤¥È¥ë International Journal of Surgery Case Reports¡¤112
¥Ú¡¼¥¸ÈÖ¹æ 108963
Ãø¼Ô Amioka J
¶¦Ãø Yanagawa S¡¤Yamamoto Y¡¤Nakahara M¡¤Yonehara S¡¤Noriyuki T

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ¥ê¥ó¥Ñ¼ðÍÍ·¿¡¿·Á¼ÁºÙ˦¼ð·¿Ç¢Ï©¾åÈé´â¤È¤Î´ÕÊ̤˶ìθ¤·¤¿¿ÕÌçÉôȯÀ¸°­À­¥ê¥ó¥Ñ¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ»¨»ï¡¡61(6)
¥Ú¡¼¥¸ÈÖ¹æ 419-423
Ãø¼Ô ¿ÀÅÄ¿¿µ¬
¶¦Ãø ÃæÅç°¦³¤¡¤±©¸¶¹¬µ±¡¤º´¡¹ÌÚ·ò»Ê¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ÆýƬʬÈç´â¤ÎÀü»ÉµÛ°úºÙ˦¿Ç¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ»¨»ï¡¡61(6)
¥Ú¡¼¥¸ÈÖ¹æ 407-412
Ãø¼Ô ÃæÅç°¦³¤
¶¦Ãø ±©¸¶¹¬µ±¡¤¿ÀÅÄ¿¿µ¬¡¤º´¡¹ÌÚ·ò»Ê¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ¼«Á³Ç¢ºÙ˦¿Ç¤ÇÁÈ¿¥·¿¤ò¿äÄꤷÆÀ¤¿Èù¾®ÆýƬ¾õǢϩ¾åÈé´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Å縩Î×¾²ºÙ˦³Ø²ñ²ñ»ï¡¡42
¥Ú¡¼¥¸ÈÖ¹æ 27-32
Ãø¼Ô ÃæÅç°¦³¤
¶¦Ãø ±©¸¶¹¬µ±¡¤ÁêÉôÀ²¹á¡¤¿ÀÅÄ¿¿µ¬¡¤º´¡¹ÌÚ·ò»Ê¡¤ÊƸ¶½¤¼£¡¤À¾Åĸ­»Ê

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ç¯æù¸¶È¯ÌÀºÙ˦´â¤ÎÇ¢ÃæºÙ˦½ê¸«
»¨»ï¥¿¥¤¥È¥ë ¹­Å縩Î×¾²ºÙ˦³Ø²ñ²ñ»ï¡¡42
¥Ú¡¼¥¸ÈÖ¹æ 20-26
Ãø¼Ô ±©¸¶¹¬µ±
¶¦Ãø ÃæÅç°¦³¤¡¤ÁêÉôÀ²¹á¡¤¿ÀÅÄ¿¿µ¬¡¤º´¡¹ÌÚ·ò»Ê¡¤ÊƸ¶½¤¼£¡¤À¾Åĸ­»Ê¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë Curative surgery for primary Squamous cell carcinoma of the liver: a rare case study¡¥
»¨»ï¥¿¥¤¥È¥ë ¡¡Clinical Journal Gastroentology¡¥16¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 263-269
Ãø¼Ô Okuda Y¡¤
¶¦Ãø Abe T¡¤Ikeda M¡¤Kurihara K¡¤Simizu A¡¤Oshita A¡¤Yonehara S¡¤Hanada K¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ÏÀʸ¥¿¥¤¥È¥ë Abnormal growth of a pleomorphic leiomyosarcoma originating from the mesenteric vein associated with poor outcome after curative-intent resection: a case report¡¥
»¨»ï¥¿¥¤¥È¥ë ¡¡Surgical case Report¡¥8¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 147
Ãø¼Ô Otabe M¡¤
¶¦Ãø Abe T¡¤Sumi Y¡¤Yonehara S¡¤Noriyuki T¡¤Nakahara M¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Metachronous colorectal liver matastasis that occurred 10 years after laparoscopic colectomy : a case report¡¥
»¨»ï¥¿¥¤¥È¥ë ¡¡Surgical case Report¡¥8¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 144
Ãø¼Ô Shidahara H¡¤
¶¦Ãø Abe T¡¤Oshita A¡¤Sumi Y¡¤Okuda H¡¤kurayoshi M¡¤Yonehara S¡¤Kobayashi T¡¤ ¡¡¡¡Ohdan H¡¤Noriyuki T¡¤Nakahara M.

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ÉÂÍý¿ÇÃDzÊ
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ¹­Å縩¤Ë¤ª¤±¤ë¾®Ä²¤¬¤óÍå´µ¡Ê2003¡Ý2018¡Ë
»¨»ï¥¿¥¤¥È¥ë JACR Monograph¡¥27
¥Ú¡¼¥¸ÈÖ¹æ 3·î11Æü
Ãø¼Ô ¡Ê°ËÆ£¡¡·Ë¡Ë
¶¦Ãø ¡Ê³ÁËÜÃÒ»Ò¡Ë¡¤¡Ê¾®ÅÄ¿ò»Ö¡Ë¡¤ÊƸ¶½¤¼£¡¤¡Ê¿ù»³ÍµÈþ¡Ë

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ÉÂÍý¿ÇÃDzÊ
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ¥¹¥Æ¥í¥¤¥ÉÃæ»ß¸å¤ËºÆȯ¤·¤¿ Pulmonary hyalinizing granuloma ¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡74¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 504¡Ý508
Ãø¼Ô ¡ÊËÌÅç¿¿µª»Ò¡Ë
¶¦Ãø ¡Ê±öëºéÀé»Ò¡Ë¡¤¡ÊºÙë¶Æ±Ê¡Ë¡¤Ìî¼¹¸À¸¡¤ËÌÅçÂó¿¿¡¤Àîºê¹­Ê¿¡¤ÎëÌÚÊþ»Ò¡¤»³ÌÚ¡¡¼Â¡¤¡ÊÀ¾Åĸ­»Ê¡Ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ÉÂÍý¿ÇÃDzÊ
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ´âÀ­Ê¢Ëì±ê¤È¤Î´ÕÊ̤òÍפ·¤¿·ë³ËÀ­Ê¢Ëì±ê¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡74¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 385¡Ý389
Ãø¼Ô ËÌÅçÂó¿¿
¶¦Ãø ¡Ê±öëºéÀé»Ò¡Ë¡¤Ìî¼¹¸À¸¡¤¡ÊËÌÅç¿¿µª»Ò¡Ë¡¤Àîºê¹­Ê¿¡¤ÎëÌÚÊþ»Ò¡¤¡ÊË̺ꡡľ¡Ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ÉÂÍý¿ÇÃDzÊ
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë JA ÈøÆ»Áí¹çɱ¡¤ÎÃÀç¹¼À´µ¤ËÂФ¹¤ë¿ÇÎŲʲ£ÃÇŪ¥Á¡¼¥à°åÎÅ¡§¹â¤¤Áê¸ß¿®Íê¤Ë´ð¤Å¤¯ÃÀ繿ÇÎÅ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡42¡Ê5¡Ë¡§
¥Ú¡¼¥¸ÈÖ¹æ 463¡Ý468
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤·ª¸¶·¼²ð¡¤ÃÓÅļéÅС¤°ÂÉôÃÒÇ·¡¤Âç²¼¾´É§¡¤ÁýÅľ°Èþ¡¤Æ︫Ϻ»Ò¡¤Â¼¾åÈþ¹á¡¤Â§¹ÔÉÒÀ¸¡¤ÃžåÈþͳµª¡¤ÈõËܿ𹾡¤ÊƸ¶½¤¼£¡¤¿¹¡¡¹À´õ¡¤ËÙÀî½ÓÆó¡¤ÎëÌÚÊþ»Ò¡¤°Âͧ͵·Ã¡¤¾®ÌîÀîÌ÷Æó¡¤ÅÄÃ涵ʸ¡¤Ê¿Æ£µ×Èþ»Ò¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ÉÂÍý¿ÇÃDzÊ
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Gradually progressive cholangiolocellular carcinoma: a case report
»¨»ï¥¿¥¤¥È¥ë Surg Case report¡¥7¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 263
Ãø¼Ô ¡ÊAkiyama K¡Ë
¶¦Ãø Abe T¡¤Oshita A¡¤Shimizu A¡¤Hanada K¡¤Yonehara S¡¤¡ÊKobayashi T¡Ë¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T¡¤Nakahara M

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ÉÂÍý¿ÇÃDzÊ
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Pathological Features and Imaging Findings in Pancreatic Carcinoma In Situ
»¨»ï¥¿¥¤¥È¥ë Pancreas¡¥ 50¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 399¡Ý404
Ãø¼Ô Hanada K
¶¦Ãø Fukuhara M¡¤¡ÊMinami T¡Ë¡¤¡ÊYano S¡Ë¡¤¡ÊIkemoto J¡Ë¡¤Shimizu A¡¤Kurihara K¡¤Okuda Y,Ikeda M¡¤¡ÊYokode M¡Ë¡¤Abe T¡¤Yonehara S¡¤¡ÊYanagisawa A¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ½é¿Ç»þ¤ËÁ°Î©Á£ÂçºÙ˦¿À·ÐÆâʬÈç´â¤È¿ÇÃǤµ¤ì¤¿£±Îã
»¨»ï¥¿¥¤¥È¥ë À¾ÆüËÜÈçÇ¢´ï²Ê¡¡81¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 65-71
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ÃæÌî˧µª¡¤³ÑÀ¾Íº°ì¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ½ÑÁ°¿ÇÃǤµ¤ì¤¿ÃÀ´ÉÆâÆýƬ¾õ¼ðáç¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡71¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 638-642
Ãø¼Ô ¡ÊÈÓÅçÆÁ¾Ï¡Ë
¶¦Ãø °ÂÉôÃÒÇ·¡¤Å·Ìî¿ÒĪ¡¤ÊƸ¶½¤¼£¡¤Â§¹ÔÉÒÀ¸¡¤Ã渶²í¹À

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Ç¢´É¤ËȯÀ¸¤·¤¿¿»½áÀ­Ç¢Ï©¾åÈé´âÌÀºÙ˦·¿¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë À¾ÆüËÜÈçÇ¢´ï²Ê¡¡80¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 614-620
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ³ÑÀ¾Íº°ì¡¤ÃæÌî˧µª¡¤ÊƸ¶½¤¼£¡¤¡Ê¶â²¬Î´Ê¿¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ç¯æù¿»½áÀ­Ç¢Ï©¾åÈé´â¡¦¥ê¥ó¥Ñ¼ðÍÍ·¿¡¿·Á¼ÁºÙ˦ÍÍ·¿¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡71¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 633-637
Ãø¼Ô ¡Ê¶â²¬Î´Ê¿¡Ë
¶¦Ãø ³ÑÀ¾Íº°ì¡¤¿¹»³¹ÀÇ·¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Æâ»ë¶À¤Ë¤ÆÁýÂç¤òǧ¤áÊ¢¹Ð¶À²¼¤ËÀÚ½ü¤·¤¿²£¹Ô·ëIJưÀÅÌ®´ñ·Á¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡71¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 552-556
Ãø¼Ô ¡Ê»³º¬¹¨¾¼¡Ë
¶¦Ãø Ã渶²í¹À¡¤±üÅÄ¡¡¹À¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ·ÐǢƻŪÀÚ½ü½Ñ¤Ë¤Æ¼£ÎŤ·¤¿°õ´ÄºÙ˦´â¤Î½ê¸«¤òȼ¤¦Ç¢Ëì´É´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡71¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 409-413
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ÊƸ¶½¤¼£¡¤¡Ê¶â²¬Î´Ê¿¡Ë¡¤³ÑÀ¾Íº°ì¡¤¡Ê¿¢ÅĽ¨Íº¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Roles of ERCP in the Eary Diagnosis of Pancreatic Cancer
»¨»ï¥¿¥¤¥È¥ë Diagnostics 9¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ pii: E30. doi: 10.3390/diagnostics9010030
Ãø¼Ô Keiji Hanada
¶¦Ãø Tomoyuki Minami¡¤Akinori Shimizu¡¤Motomitu Fukuhara¡¤Shigeki Yano¡¤Kenji Sasaki¡¤Masanori Koda¡¤Kayo Suguyama¡¤Syuji Yonehara¡¤And¡ÊAkio Yanagisawa¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Endoscopic ultrasound findings and pathological features of pancreatic carcinoma in situ
»¨»ï¥¿¥¤¥È¥ë Endoscopy International open¡Ê07¡Ë
¥Ú¡¼¥¸ÈÖ¹æ E585¡ÝE593
Ãø¼Ô ¡ÊYoshio Izumi¡Ë
¶¦Ãø Keiji Hanada¡¤¡ÊAkihito Okazaki¡Ë¡¤Tomoyuki Minami¡¤Naomichi Hirano¡¤¡ÊJuri Ikemoto¡Ë¡¤¡ÊKozue kanemitsu¡Ë¡¤Koichi Nakadoi¡¤Takayoshi Shishido¡¤Yoshio Katamura¡¤Seiji Onogawa¡¤Hajima Amano¡¤Fumiaki Hino¡¤Hironobu Amano¡¤Shuji Yonehara.

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Efficacy and safety of early cholecystectomy for comorbid acute cholecystitis and acute cholangitis:Retrospective cohort study.
»¨»ï¥¿¥¤¥È¥ë Ann Med Surg¡Ê Lond¡Ë¡¥38
¥Ú¡¼¥¸ÈÖ¹æ 8-12
Ãø¼Ô Tomoyuki Abe
¶¦Ãø Hironobu Amano¡¤Keiji Hanada¡¤Tomoaki Bekki¡¤Tomoyuki Minami¡¤Shuji Yonehara¡¤Toshio Noriyuki¡¤Masahiro Nakahara

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Historical Changes in Histological Diagnosis of Lung Cancer
»¨»ï¥¿¥¤¥È¥ë J Epidemiol. 29¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 238-240
Ãø¼Ô ¡ÊMai Utada¡Ë
¶¦Ãø Shuji Yonehara¡¤and¡ÊKotaro Ozasa¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Characteristics of Benign and Malignant Bone Tumors Registered in the Hiroshima Tumor Tissue Registry¡¤1973¡Ý2012
»¨»ï¥¿¥¤¥È¥ë JB JS Open Access. 3¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ e0064. doi: 10.2106/JBJS.OA.17.00064¡¤2018
Ãø¼Ô ¡ÊHiromi Sugiyama¡Ë
¶¦Ãø ¡ÊKunihiro Omonishi¡Ë¡¤Shuji Yonehara¡¤¡ÊKotaro Ozasa¡Ë¡¤¡ÊHiroki Kajihara¡Ë¡¤¡ÊTakafumi Tsuya¡Ë¡¤¡ÊYukio Takeshima¡Ë¡¤and on behalf of the Hiroshima Tumor Tissue

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Characteristics of the portal vein thrombosis recurrence pattern without liver parenchymal invasion from colorectal cancer: a case report
»¨»ï¥¿¥¤¥È¥ë Surgical Case Report 4
¥Ú¡¼¥¸ÈÖ¹æ 108
Ãø¼Ô ¡ÊTetsuya Mochizuki¡Ë
¶¦Ãø Tomoyuki Abe¡¤Hironobu Amano¡¤Kenji Nishida¡¤Takuya Yano¡¤Hiroshi Okuda¡¤¡ÊTsuyoshi Kobayashi¡Ë¡¤¡ÊHideki Ohdan¡Ë¡¤Shuji Yonehara¡¤Toshio Noriyuki¡¤and Masahiro Nakahara

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Metachronous triple cancer associated with Peutz-Jeghers syndrome treated with curative surgery: a case report
»¨»ï¥¿¥¤¥È¥ë Surgical Case Reports 4
¥Ú¡¼¥¸ÈÖ¹æ 84
Ãø¼Ô ¡ÊToru Yoshikawa¡Ë
¶¦Ãø Tomoyuki Abe¡¤Hironobu Amano¡¤Keiji Hanada¡¤Tomoyuki Minami¡¤¡ÊTsuyoshi Kobayashi¡Ë¡¤Shuji Yonehara¡¤Masahiro Nakahara¡¤¡ÊHideki Ohdan¡Ë¡¤and Toshio Noriyuki.

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Prospective Follow-up Study of the Recurrence of Pancreatic cancer Diagnosed at an Early Stage -The Value of Endoscopic Ultrasonography for Early Diagnosis of Recurrence in the Remnant Pancreas
»¨»ï¥¿¥¤¥È¥ë Pancreas 47
¥Ú¡¼¥¸ÈÖ¹æ 482-488
Ãø¼Ô ¡ÊJuri Ikemoto¡Ë
¶¦Ãø Keiji Hanada¡¤Tomoyuki Minami¡¤¡ÊAkihito Okazaki¡Ë¡¤Tomoyuki Abe¡¤Hironobu Amano¡¤Shuji Yonehara

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ç¯æù¿»½áÀ­Ç¢Ï©¾åÈé´âÌÀºÙ˦·¿¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡71¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 209¡Ý212
Ãø¼Ô ³ÑÀ¾Íº°ì
¶¦Ãø ¿¹»³¹ÀÇ·¡¤¶â²¬Î´Ê¿¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Genetic analyses of isolated high-glade pancreatic intraepithelial neoplasia¡Ê HG-PanIN¡Ëreveal paucity of alterations in TP53 and SMAD4¡¥
»¨»ï¥¿¥¤¥È¥ë J Pathol.¡¡242¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 16¡Ý23
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊHosoda W¡Ë¡¤¡ÊChianchiano P¡Ë¡¤¡ÊGriffin JF¡Ë¡¤¡ÊPittman ME¡Ë¡¤¡ÊBrosen LA¡Ë¡¤¡ÊNoe M¡Ë¡¤¡ÊYu J¡Ë¡¤¡Êshindo K¡Ë¡¤¡ÊSuenaga M¡Ë¡¤¡ÊRezaee N¡Ë¡¤¡ÊYonescu R¡Ë¡¤¡ÊNing Y¡Ë¡¤¡ÊAlbores-Saavedra J¡Ë¡¤¡ÊYoshizawa N¡Ë¡¤¡ÊHarada K¡Ë¡¤¡ÊYoshizawa A¡Ë¡¤Yonehara S¡¤¡ÊShimizu M¡Ë¡¤¡ÊUehara T¡Ë¡¤¡ÊSamra JS¡Ë¡¤¡ÊGill AJ¡Ë¡¤¡ÊWolfgang CL¡Ë¡¤¡ÊGoggins MG¡Ë¡¤¡ÊHruban RH¡Ë¡¤¡ÊWood LD¡Ë

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë A case of cholangiolocellular carcinoma featuring intratumoral hepatic artery penetration: A case report
»¨»ï¥¿¥¤¥È¥ë International Journal of Surgery Case Report¡¡35
¥Ú¡¼¥¸ÈÖ¹æ 77¡Ý81
Ãø¼Ô Tomoyuki Abe
¶¦Ãø ¡ÊHiroaki Yamane¡Ë¡¤Hironobu Amano¡¤¡ÊTsuyoshi Kobayasi¡Ë¡¤Keiji hanada¡¤Shuji Yonehara¡¤¡ÊHideki Ohdan¡Ë¡¤Masahiro Nakahara¡¤¡ÊToshio Noriyuki¡Ë

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ·ÐÆýƬŪÃÀ´É¡¦ç¹´ÉÀ¸¸¡¤ÈºÙ˦¿Ç
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡29¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 847¡Ý852
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤¡Ê²¬ºê¾´¿Î¡Ë¡¤¡ÊÃÓËܼî轡ˡ¤Ê¡¸¶´ð°ô¡¤Ê¿ÌîµðÄÌ¡¤º´¡¹ÌÚ·ò»Ê¡¤¿ù»³²ÂÂ塤¿ÀÅÄ¿¿µ¬¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ÃÀǹ¸¶È¯¾®ºÙ˦¿À·ÐÆâʬÈç´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ»¨»ï¡¡56¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 182¡Ý188
Ãø¼Ô ¿ù»³²ÂÂå
¶¦Ãø ÊÆëµ×Èþ»Ò¡¤¿ÀÅÄ¿¿µ¬¡¤º´¡¹ÌÚ·ò»Ê¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ç¯æù¿»½áÀ­Ç¢Ï©¾åÈé´âµðºÙ˦·¿¤Î£²Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡70¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 264¡Ý267
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ÊƸ¶½¤¼£¡¤¶â²¬Î´Ê¿¡¤³ÑÀ¾Íº°ì

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ç¹¾åÈéÆâ´â½Ñ¸å¤Ë»Äç¹´â¤òǧ¤á¡¤»Äç¹Á´Å¦½Ñ¤ò»Ü¹Ô¤·¤¿£²Îã
»¨»ï¥¿¥¤¥È¥ë Gastroenterological Endoscopy¡¡59¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1638¡Ý1643
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÃÓËܼî轡ˡ¤Æî¡¡ÃÒÇ·¡¤Ê¡¸¶´ð°ô¡¤¡Ê²¬ºê¾´¿Î¡Ë¡¤Ê¿ÌîµðÄÌ¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¸åÊ¢Ëì¶À²¼¤ËŦ½ù¤·¤¿¿ÕÊ¿³ê¶Ú¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡70¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 402¡Ý405
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¶â²¬Î´Ê¿¡¤³ÑÀ¾Íº°ì¡¤ÊƸ¶½¤¼£¡¤¡ÊÇòºêµÁÈÏ¡Ë

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¥Í¥Õ¥í¡¼¥¼¾É¸õ·²¤ò·Àµ¡¤Ëȯ¸«¤µ¤ì¤¿¸åÊ¢Ëì»éËÃÆù¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡70¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 383¡Ý386
Ãø¼Ô ¶â²¬Î´Ê¿
¶¦Ãø ³ÑÀ¾Íº°ì¡¤¿¹»³¹ÀÇ·¡¤ÊƸ¶½¤¼£¡¤¡ÊÀ¶¿åÈþÆà»Ò¡Ë¡¤¹¾ºê¡¡Î´

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma
»¨»ï¥¿¥¤¥È¥ë ANTICANCER RESEARCH¡¡37
¥Ú¡¼¥¸ÈÖ¹æ 5863¡Ý5870
Ãø¼Ô Tomoyuki Abe
¶¦Ãø Hironobu Amano¡¤Keiji Hanada¡¤Tomoyuki Minami¡¤Shuji Yonehara¡¤¡ÊMinoru Hattori¡Ë¡¤¡ÊTsuyoshi Kobayashi¡Ë¡¤¡ÊToshikatsu Fukuda¡Ë¡¤Msahiro Nakahara¡¤¡ÊHideki Ohdan¡Ë and Toshio Noriyuki

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Ê¢ËìÆ©ÀÏÃæ¤Ëç¹¼ðáî¤ò»ØŦ¤µ¤ìĶ²»ÇÈÆâ»ë¶À²¼Àü»ÉµÛ°úË¡¤Ë¤Æç¹´â¤È³ÎÄê¿ÇÃǤ·¤¿£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡70¡Ê10¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 438¡Ý441
Ãø¼Ô Ç𸶺Ìǵ
¶¦Ãø Æî¡¡ÃÒÇ·¡¤¹¾ºê¡¡Î´¡¤¡ÊÂçµ×ÊÝ°¦»Ò¡Ë¡¤Ê¡¸¶´ð°ô¡¤¡ÊÃÓËܼî轡ˡ¤²ÖÅķɻΡ¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë EUS-FNA »ä¤Ï¤³¤¦¤¹¤ë
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡Î×»þÁý´©ÆÃÂç¹æ¡¡38
¥Ú¡¼¥¸ÈÖ¹æ 951¡Ý957
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤´Ý»³¹É»Ì¡¤¿¹¡¡±Ñµ±¡¤Ê¡¸¶´ð°ô¡¤ÌðÌîÀ®¼ù¡¤Æî¡¡ÃÒÇ·¡¤º´¡¹ÌÚ·ò»Ê¡¤¿ÀÅÄ¿¿µ¬¡¤¿ù»³²ÂÂ塤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ½Ñ¸å£´Ç¯ÌܤË¿ȯ±ó³Öž°ÜºÆȯ¤ò¤­¤¿¤·¤¿Áá´üÂçIJ´â¡ÊT1b¡Ë¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²³°²Ê³Ø²ñ»¨»ï¡¡78¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 2703¡Ý2709
Ãø¼Ô ÊÌÌÚÃÒ¾¼
¶¦Ãø Ã渶²í¹À¡¤°ÂÉôÃÒÇ·¡¤ÌðÌîÂöÌ顤±üÅÄ¡¡¹À¡¤ÊƸ¶½¤¼£¡¤Å·Ìî¿ÒĪ

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¼ª²¼Á£¾åÈé¶Ú¾åÈé´â¤ÎÀü»ÉµÛ°úºÙ˦Áü
»¨»ï¥¿¥¤¥È¥ë ¹­Å縩Î×¾²ºÙ˦³Ø²ñ»ï¡¡38
¥Ú¡¼¥¸ÈÖ¹æ 5-7
Ãø¼Ô º´¡¹ÌÚ·ò»Ê
¶¦Ãø ²ÃÆ£µ®»Ò¡¤ÁêÉôÀ²¹á¡¤¿ù»³²ÂÂ塤¿ÀÅÄ¿¿µ¬¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/07

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¼«Á³Ç¢ºÙ˦¿Ç¤ÇÁÈ¿¥·¿¤ò¿äÄꤷÆÀ¤¿ÆýƬ¾õ¿ÕºÙ˦´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Å縩Î×¾²ºÙ˦³Ø²ñ»ï¡¡38
¥Ú¡¼¥¸ÈÖ¹æ 77¡Ý82
Ãø¼Ô ¿ÀÅÄ¿¿µ¬
¶¦Ãø ²ÃÆ£µ®»Ò¡¤ÁêÉôÀ²¹á¡¤¿ù»³²ÂÂ塤º´¡¹ÌÚ·ò»Ê¡¤ÊƸ¶½¤¼£¡¤¿¹»³¹ÀÇ·

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ¼«¸ÊÌȱÖÀ­ÇÙ˦ÃÁÇò¾É¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Å縩Î×¾²ºÙ˦³Ø²ñ»ï¡¡37
¥Ú¡¼¥¸ÈÖ¹æ 67¡Ý71
Ãø¼Ô ¿ù»³²ÂÂå
¶¦Ãø ÁêÉôÀ²¹á¡¤¿ÀÅÄ¿¿µ¬¡¤º´¡¹ÌÚ·ò»Ê¡¤ÊƸ¶½¤¼£¡¤ÆÁÌÓ·òÂÀϺ¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Æâ»ë¶ÀŪ·Ðɡ繴ɥɥì¥Ê¡¼¥¸Î±ÃÖ²¼ç¹±ÕºÙ˦¿Ç¤Ë¤ª¤±¤ëç¹¾åÈéÆâ¼ðáçÀ­ÉÂÊѤδÕÊÌ
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ»¨»ï¡¡56¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1¡Ý8
Ãø¼Ô º´¡¹ÌÚ·ò»Ê
¶¦Ãø ¿ù»³²ÂÂ塤¿ÀÅÄ¿¿µ¬¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Åö±¡¤Ë¤ª¤±¤ëÊ¢¹ÐÆâ¶À²¼Á°Î©Á£Á´Å¦½ü½Ñ¤Î½é´ü·Ð¸³
»¨»ï¥¿¥¤¥È¥ë À¾ÆüÈçÇ¢¡¡78
¥Ú¡¼¥¸ÈÖ¹æ 609¡Ý614
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡ÊµÈÌî´³¾ë¡Ë¡¤¡Ê´ØÌîÍÛÊ¿¡Ë¡¤¡ÊÂ縶¿µÌé¡Ë¡¤¡ÊÈËÅÄÀµ¿®¡Ë¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ±Ö³Ø¡§¤È¤¯¤ËIPMN ʻ¸繴â¤Ë¤Ä¤¤¤Æ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡37¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1437¡Ý1442
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤²¬ºê¾´¿Î¡¤Ê¿ÌîµðÄÌ¡¤ÃÓËܼî轡¤Ê¡¸¶´ð°ô¡¤°ÂÉôÃÒÇ·¡¤Å·Ìî¿ÒĪ¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤκÇÁ°Àþ
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀç¹¼£¸¦»ï¡¡14¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 5¡Ý11
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤²¬ºê¾´¿Î¡¤¡ÊÀô¡¡ÎÉ´²¡Ë¡¤ÃÓËܼî轡¤¡Ê·ó¸÷¡¡¾¿¡Ë¡¤Ê¿ÌîµðÄÌ¡¤¼µ¸Í¹§¹¥¡¤ÃæÅÚ°æ¹Ý°ì¡¤¾®ÌîÀîÌ÷Æó¡¤ÊÒ¼²ÅÃË¡¤Å·Ìî¡¡»Ï¡¤ÆüÌîʸÌÀ¡¤Å·Ìî¿ÒĪ¡¤°ÂÉôÃÒÇ·¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ¿»½áÀ­ç¹´É´â¤È¤Î´ÕÊ̤ËÆñ½Â¤·EUS-FNA ¤¬¿ÇÃǤËÍ­ÍѤǤ¢¤Ã¤¿ÇÙÁ£´âç¹Å¾°Ü¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë Æü¾Ã»ï¡¡113
¥Ú¡¼¥¸ÈÖ¹æ 1401¡Ý1407
Ãø¼Ô ÃÝ°æÂçÍ´
¶¦Ãø ²¬ºê¾´¿Î¡¤Æî¡¡ÃÒÇ·¡¤ÃÓËܼî轡¤Ê¿ÌîµðÄÌ¡¤²ÖÅķɻΡ¤¡Ê»û²¬Íº»Ë¡Ë¡¤¡ÊÊ¡ÅÄÉÒ¾¡¡Ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Ç¢´É¼ðáç¤È¤Î´ÕÊ̤¬º¤Æñ¤Ç¤¢¤Ã¤¿¸¶È¯À­¸Â¶ÉÀ­Ç¢´É¥¢¥ß¥í¥¤¥É¡¼¥·¥¹¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡69¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 566¡Ý569
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê³á¸¶¡¡½¼¡Ë¡¤ÊƸ¶½¤¼£¡¤¡Ê±Ê°æ¡¡¹¸¡Ë

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë GEM+CBDCA ÎÅË¡¤ÈÊü¼ÍÀþÎÅË¡¤ÎÊ»ÍѤ¬Í­¸ú¤Ç¤¢¤Ã¤¿ç¯æùÁ£´â¡¦°õ´ÄºÙ˦°¡·¿¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡69¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 488¡Ý491
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡ÊµÈÌî´³¾ë¡Ë¡¤¡Ê¹âß·¿®¹¥¡Ë¡¤ÊƸ¶½¤¼£¡¤¡ÊÃ涿µÈÆóϺ¡Ë¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ľIJ´â°Û»þÀ­Ê¢ËìÇżïºÆȯ¤ËÂФ·¤Æç¹Æ¬½½Æó»ØIJÀÚ½ü½Ñ¤ò»Ü¹Ô¤·Ä¹´üÀ¸Â¸¤òÆÀ¤¿£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÂçIJæêÌçɲñ»ï¡¡69
¥Ú¡¼¥¸ÈÖ¹æ 276¡Ý281
Ãø¼Ô Ã渶²í¹À
¶¦Ãø ¡Êã·Æ£Îµ½õ¡Ë¡¤Ã渶²í¹À¡¤¡ÊµÈÅÄ¡¡À¿¡Ë¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Docetaxel ÎÅË¡¤Î¸ú²Ì¤òǧ¤á¤¿¸¶È¯À­Á°Î©Á£Ù¨Ê¿¾åÈé´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÈçÇ¢µªÍס¡62
¥Ú¡¼¥¸ÈÖ¹æ 259¡Ý264
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê³á¸¶¡¡½¼¡Ë¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Complete spontaneous necrosis of hepatocellular carcinoma confirmed on resection:A case report
»¨»ï¥¿¥¤¥È¥ë International journal of surgery¡¡22
¥Ú¡¼¥¸ÈÖ¹æ 70¡Ý74
Ãø¼Ô Hironobu Amano
¶¦Ãø ¡ÊRyusuke Saito¡Ë¡¤Tomoyuki Abe¡¤Nobuaki Fujikuni¡¤Masahiro Nakahara¡¤Syuuji Yonehara¡¤¡ÊKazushi Teramen¡Ë¡¤Toshio Noriyuki.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Preoperative systemic inflammation and complications affect long-term gallbladder carcinoma outcomes following surgery with curative Intent
»¨»ï¥¿¥¤¥È¥ë Anticancer research¡¡36
¥Ú¡¼¥¸ÈÖ¹æ 4887¡Ý4894
Ãø¼Ô Tomoyuki Abe
¶¦Ãø Hironobu Amano¡¤Keiji Hanada¡¤Shuji Yonehara¡¤¡ÊKobayasi Tuyoshi¡Ë¡¤
¡¡¡¡¡ÊToshikatsu Fukuda¡Ë¡¤Masahiro Nakahara¡¤Yosinori Kuroda¡¤Toshio Noriyuki.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë A spindle cell anaplastic pancreatic carcinoma with rhabdoid features following Curative resection
»¨»ï¥¿¥¤¥È¥ë Molecular and clinical oncology¡¡5
¥Ú¡¼¥¸ÈÖ¹æ 327¡Ý330
Ãø¼Ô Tomoyuki Abe
¶¦Ãø Hironobu Amano¡¤Keiji Hanada¡¤Akihito Okazaki¡¤Shuji Yonehara¡¤¡ÊFumito Kuranishi¡Ë¡¤Masahiro Nakahara¡¤Yoshinori Kuroda¡¤Toshio Noriyuki.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë A case of juvenile polyposis of the stomach with multiple early gastric cancer
»¨»ï¥¿¥¤¥È¥ë Molecular and clinical oncology¡¡4
¥Ú¡¼¥¸ÈÖ¹æ 851¡Ý854
Ãø¼Ô Nobuaki Fujikuni
¶¦Ãø ¡ÊRyusuke Saito¡Ë¡¤¡ÊToshikatu Fukuda¡Ë¡¤Tomoyuki Abe¡¤Hironobu Amano¡¤Masahiro Nakahara¡¤Syuji Yonehara¡¤Toshio Noriyuki

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Follicular cholangitis associated with focal biliary stricture treated with left Hepatectomy after 8years of follow-up:A rare case report
»¨»ï¥¿¥¤¥È¥ë Molecular and clinical oncology¡¡4
¥Ú¡¼¥¸ÈÖ¹æ 114¡Ý118
Ãø¼Ô Hironobu Amano
¶¦Ãø ¡ÊRyusuke Saito¡Ë¡¤¡ÊToshikatu Fukuda¡Ë¡¤Masahiro Nakahara¡¤¡ÊMakoto Yoshida¡Ë¡¤Minoru Yamaki¡¤Keiji Hanada¡¤Shuji Yonehara¡¤Toshio Noriyuki.

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Follicular cholangitis associated with focal biliary stricture treated with left hepatectomy after 8 years of¡¡follow-up: A rare case report.
»¨»ï¥¿¥¤¥È¥ë Mol Clin Oncol.¡¡£´¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 114¡Ý118
Ãø¼Ô Saito R¡¤
¶¦Ãø ¡ÊFukuda T¡Ë¡¤Amano H¡¤Nakahara M¡¤Yoshida M¡¤Yamaki M¡¤Hanada K¡¤Yonehara S¡¤Noriyuki T.

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ¡¡µÞ®¤Ê·Ð²á¤òé¤Ã¤¿Âà·ÁÀ®ç¹´É´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡25
¥Ú¡¼¥¸ÈÖ¹æ 21¡Ý25
Ãø¼Ô ÏÂÅĤ¢¤º¤µ
¶¦Ãø ¡Ê»û²¬ÍºÍù¡Ë¡¤Ê¿ÌîµðÄÌ¡¤²ÖÅķɻΡ¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë Multicentric solid pseudopapillary neoplasms of the pancreas diagnosed by endoscopic ultrasound-guided¡¡fine needle aspiration: a case report
»¨»ï¥¿¥¤¥È¥ë Surg Case Rep.¡¡£±¡Ê1¡Ë
Ãø¼Ô ¡ÊM. Yamaguchi¡Ë
¶¦Ãø ¡ÊT. Fukuda¡Ë¡¤M. Nakahara¡¤¡ÊM. Amano¡Ë¡¤D. Takei¡¤¡ÊM. Kawashima¡Ë¡¤¡ÊY. Sumi¡Ë¡¤H. Amano¡¤S. Yonehara¡¤K. Hanada¡¤T. Noriyuki.

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ½Ä³Ö¥ê¥ó¥ÑÀឰܤËÂФ·Å¦½Ð½Ñ¤ò¹Ô¤Ã¤¿¸¶È¯ÁãÉÔÌÀÈé¼ð
»¨»ï¥¿¥¤¥È¥ë ¶»Éô³°²Ê¡¡68¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 941¡Ý943
Ãø¼Ô »³ÌÚ¡¡¼Â
¶¦Ãø §¹ÔÉÒÀ¸¡¤ÃÝ°æÂçÍ´¡¤ÃݸµÍºµª¡¤óîƣε½õ¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ç¹¾åÈéÆâ´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡68¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 367¡Ý368
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ²¬ºê¾´¿Î¡¤Àô¡¡ÎÉ´²¡¤Ê¿ÌîµðÄÌ¡¤Å·Ìî »Ï¡¤¾®ÌîÀîÌ÷Æ󡤡ʺ£À¼ù¡Ë¡¤ÃæÅÚ°æ¹Ý°ì¡¤¡Ê»û²¬ÍºÍù¡Ë¡¤ ÃÓËܼî轡¤·ó¸÷¡¡¾¿¡¤ÆüÌîʸÌÀ¡¤Ê¡ÅÄÉÒ¾¡¡¤Å·Ìî¿ÒĪ¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ÀÖ·ìµåÁý¿¾É¤òȼ¤Ã¤¿¥¨¥ê¥¹¥í¥Ý¥¨¥Á¥ó»ºÀ¸¿ÕºÙ˦´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡68¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 380¡Ý385
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡ÊµÈÌî´³¾ë¡Ë¡¤ÊƸ¶½¤¼£¡¤Ã渶²í¹À¡¤ÆüÌîʸÌÀ¡¤¿¹¡¡¹À´õ¡¤¡ÊÂçÅijÀÇîʸ¡Ë

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë Skin Cancer Incidence among Atomic Bomb Survivors from 1958 to 1996
»¨»ï¥¿¥¤¥È¥ë RADIATION RESEARCH¡¡
¥Ú¡¼¥¸ÈÖ¹æ 531¡Ý539
Ãø¼Ô ¡ÊHiromi Sugiyama¡Ë
¶¦Ãø ¡ÊMunechika Misumi¡Ë¡¤¡ÊMasao Kishikawa¡Ë¡¤¡ÊMasachika Iseki¡Ë¡¤Shuji Yonehara¡¤¡ÊTomayoshi Hayashi¡Ë¡¤¡ÊMidori Soda¡Ë¡¤¡ÊShoji Tokuoka¡Ë¡¤¡ÊYukiko Shimizu¡Ë¡¤¡ÊRitsu Sakata¡Ë¡¤¡ÊEric JGrant¡Ë¡¤¡ÊFumiyoshi Kasagi¡Ë¡¤¡ÊKiyohiko Mabuchi¡Ë¡¤¡ÊAkihiko Suyama¡Ë¡¤¡ÊKotaro Ozasa¡Ë

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ³ËÆâºÙ˦¼ÁÉõÆþÂΤΤߤé¤ì¤¿¹Ã¾õÁ£Á£¼ðÍÍ·ëÀá¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüÎ׺Ù˦¹­Åç²ñ»ï¡¡34
¥Ú¡¼¥¸ÈÖ¹æ 25¡Ý29
Ãø¼Ô ¿ù»³²ÂÂå
¶¦Ãø ÊÆëµ×Èþ»Ò¡¤ÁêÉôÀ²¹á¡¤¿ÀÅÄ¿¿µ¬¡¤º´¡¹ÌÚ·ò»Ê¡¤ÊƸ¶½¤¼£¡¤Â§¹ÔÉÒÀ¸¡¤½ÕÅĤë¤ß

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ˶¸¡¤Ë¤è¤ê¿ÇÃǤµ¤ì¤¿¸¶È¯À­ç¯æùÁ£´â¡¦°õ´ÄºÙ˦°¡·¿¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡67
¥Ú¡¼¥¸ÈÖ¹æ 55¡Ý58
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌî´³¾ë¡¤Â縶¿µÌ顤ÊƸ¶½¤¼£¡¤µÜ¿¹âü£

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¿˼ǹ˦À­¿ÕºÙ˦´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡23
¥Ú¡¼¥¸ÈÖ¹æ 13¡Ý16
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌî´³¾ë¡¤Â縶¿µÌ顤ÊƸ¶½¤¼£¡¤ÆüÌîʸÌÀ

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Èé»éÁ£´â¤Ø¤Î°­À­Å¾²½¤ò¤­¤¿¤·¤¿ÍñÁãÀ®½Ïǹ˦À­´ñ·Á¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸½Â建ÉؿͲʡ¡62
¥Ú¡¼¥¸ÈÖ¹æ 69¡Ý72
Ãø¼Ô »û²¬Í­»Ò
¶¦Ãø ¡ÊÀî¾åÍβð¡Ë¡¤Íê¡¡±ÑÈþ¡¤ÊƸ¶½¤¼£¡¤º´¡¹ÌÚ¹î

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¥²¥Õ¥£¥Á¥Ë¥Ö¤¬ÁÕ¸ú¤·¤¿¤¬³ÍÆÀÂÑÀ­²½¤·¤¿¤¿¤á¥µ¥ë¥Ù¡¼¥¸¼ê½Ñ¤ò»Ü¹Ô¤·¤¿ºÆȯÇÙ´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËܸƵ۴ﳰ²Ê³Ø²ñ¡¡27
¥Ú¡¼¥¸ÈÖ¹æ 26¡Ê812¡Ë¡Ý30¡Ê816¡Ë
Ãø¼Ô »³ÌÚ¡¡¼Â
¶¦Ãø §¹ÔÉÒÀ¸¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Æý´â¤È´Ö°ã¤ï¤ì¤ä¤¹¤¤²èÁü½ê¸«¤òÄ褷¤¿ÆýÁ£Àþ¶Ú¾åÈé¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë Î׳°¡¡68
¥Ú¡¼¥¸ÈÖ¹æ 1099¡Ý1102
Ãø¼Ô ¡ÊµÈ¼µª»Ò¡Ë
¶¦Ãø ½ÕÅĤë¤ß¡¤²ÏÅççýÀ¡¡¤»³¸ý·ÃÈþ¡¤¡Ê¹â¶¶¡¡¸µ¡Ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë 30Âå½÷À­¤Î¼ãǯÀ­Àþ°ÝÁ£¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66
¥Ú¡¼¥¸ÈÖ¹æ 521¡Ý522
Ãø¼Ô ¡ÊµÈ¼µª»Ò¡Ë
¶¦Ãø º´¡¹ÅÄãÀ®¡¤²ÏÅççýÀ¡¡¤»³¸ý·ÃÈþ¡¤¡Ê¹â¶¶¡¡¸µ¡Ë¡¤¡ÊÃæÌîμ²ð¡Ë¡¤½ÕÅĤë¤ß¡¤Â§¹ÔÉÒÀ¸¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ½Ð·ìÀ­¿Õǹ˦¤È¤Î¼±Ê̤¬º¤Æñ¤Ç¤¢¤Ã¤¿Ç¹Ë¦¾õ¿ÕºÙ˦´â¤Î£²Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66
¥Ú¡¼¥¸ÈÖ¹æ 496¡Ý501
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌî´³¾ë¡¤ÊƸ¶½¤¼£¡¤Àµ²¬ÃÒ»Ò¡¤À¥Èø°ì»Ë

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë CEA¡¤CA19?9¡¤AFP ¤Î¹âÃͤ«¤éºÆdz¤¬È½ÌÀ¤·¤¿Á°Î©Á£´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66
¥Ú¡¼¥¸ÈÖ¹æ 377¡Ý382
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¾¾ËÜͦ¼¡¡¤µÈÌî´³¾ë¡¤Ê¿ÌîµðÄÌ¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ²¼ÂçÀÅÌ®¼ðáçÀò¤òȼ¤Ã¤¿¦Á-fetoprotein »ºÀ¸°ß´â¤Î´Îž°Ü¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66
¥Ú¡¼¥¸ÈÖ¹æ 329¡Ý334
Ãø¼Ô ¡ÊÃ漿¿Ìé¡Ë
¶¦Ãø Ê¡ËÜ¡¡¹¸¡¤»û²¬ÍºÍù¡¤Å·ÌîÈþ½ï¡¤¡Ê»³Íº·òÂÀϺ¡Ë¡¤¡Ê¶¶ËܵÁÀ¯¡Ë¡¤ÈÓÀ±ÃÎÇ¾®ÌîÀîÌ÷Æó¡¤Ê¿ÌîµðÄÌ¡¤²ÖÅķɻΡ¤Å·Ìî¡¡»Ï¡¤ÆüÌîʸÌÀ¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Ĺ´üÆ©ÀÏ´µ¼Ô¤Î¸åÅ·À­Ç¹Ë¦À­¿Õ¼À´µ¤Ë¹çÊ»¤·¤¿Î¾Â¦¿ÕºÙ˦´â¤Î£²Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66
¥Ú¡¼¥¸ÈÖ¹æ 318¡Ý324
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌî´³¾ë¡¤¹¾ºê¡¡Î´¡¤¾¡Ã«¾»Ê¿¡¤ÊƸ¶½¤¼£¡¤Íî¹ç¿¿Íý»Ò¡¤É͸ýľ¼ù¡¥

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¥À¥Ö¥ë¥Ð¥ë¡¼¥ó¾®Ä²Æâ»ë¶À¤ÇÃîÂΤòŦ½Ð¤·ÆÀ¤¿¾®Ä²¥¢¥Ë¥µ¥­¥¹¾É¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë Gastroenterol Endosc¡¡55
¥Ú¡¼¥¸ÈÖ¹æ 1643¡Ý9
Ãø¼Ô Å·ÌîÈþ½ï
¶¦Ãø Ê¡ËÜ¡¡¹¸¡¤¡Ê»³Íº·òÂÀϺ¡Ë¡¤º£À¼ù¡¤¡Ê¶¶ËܵÁÀ¯¡Ë¡¤ÈÓÀ±ÃÎÇ¾®ÌîÀîÌ÷Æó¡¤Ê¿ÌîµðÄÌ¡¤²ÖÅķɻΡ¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Gcarbo ÎÅË¡¤¬ÁÕ¸ú¤·¤¿ç¯æùǢϩ¾åÈé´â¡¦Èù¾®ÆýƬ·¿¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÈçÇ¢´ï³°²Ê¡¡26
¥Ú¡¼¥¸ÈÖ¹æ 859¡Ý864
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌî´³¾ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Æâ»ë¶ÀŪ·Ðɡ繴ɥɥì¥Ê¡¼¥¸Î±ÃÖ²¼¤ÇºÎ¼è¤µ¤ì¤¿ç¹±ÕºÙ˦¿Ç¤ÎÍ­ÍÑÀ­¡½¾åÈéÆâ´â¡¡¤ÎºÙ˦Áü¤òÃæ¿´¤Ë¡½
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ¹­Å縩»ÙÉô²ñ»ï¡¡33
¥Ú¡¼¥¸ÈÖ¹æ 57-62
Ãø¼Ô ¿ù»³²ÂÂå
¶¦Ãø ã·Æ£µ×Èþ»Ò¡¢ÁêÉôÀ²¹á¡¢¿ÀÅÄ¿¿µ¬¡¢º´¡¹ÌÚ·ò»Ê¡¢ÊƸ¶½¤¼£¡¢²ÖÅķɻΡ¢¡¡ÈÓÀ±ÃÎÇî

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Æâ»ë¶ÀŪ·Ðɡ繴ɥɥì¥Ê¡¼¥¸Î±ÃÖ²¼¤ÇºÎ¼è¤µ¤ì¤¿ç¹±ÕºÙ˦¿Ç¤ÎÍ­ÍÑÀ­¡Ý¾åÈéÆâ´â¤ÎºÙ˦Áü¤òÃæ¿´¤Ë¡Ý
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ¹­Å縩»ÙÉô²ñ»ï¡¡Âè33´¬
¥Ú¡¼¥¸ÈÖ¹æ 57-62
Ãø¼Ô ¿ù»³²ÂÂå
¶¦Ãø óîÆ£µ×Èþ»Ò,¡¡ÁêÉôÀ²¹á,¡¡¿ÀÅÄ¡¡¿¿µ¬,¡¡º´¡¹ÌÚ·ò»Ê,¡¡ÊƸ¶½¤Æó,¡¡²ÖÅÄ·É»Î,¡¡ÈÓÀ±ÃÎÇî¡¡

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ¿©Æ»Á´°è¤Ë¿ȯ mucosal bridge ¤Î·ÁÀ®¤òǧ¤á¤¿£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66
¥Ú¡¼¥¸ÈÖ¹æ 197-199
Ãø¼Ô ¾®Ìî¹­°ì
¶¦Ãø ÉðÅľ»¼£,¡¡ÊƸ¶½¤¼£,¡¡²¬ºê½ãÆó

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ç¯æù¡¡nephrogenic adenoma¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66
¥Ú¡¼¥¸ÈÖ¹æ 190-192
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌîÀé¾ë,¡¡ÊƸ¶½¤¼£,¡¡(Àк¬Åµ¹¬)

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Ç¢´ÉǢϩ¾åÈé´â¡¦Èù¾®ÆýƬ·¿¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÈçÇ¢´ï²ÊµªÍס¡59
¥Ú¡¼¥¸ÈÖ¹æ 23-26
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌîÀé¾ë,¡¡ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ľIJ¶¹ºõ¤Ë¤è¤ë¥¤¥ì¥¦¥¹¤òȯ¾É¤·¤Æȯ¸«¤µ¤ì¤¿Á°Î©Á£´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡22
¥Ú¡¼¥¸ÈÖ¹æ 27-30
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌîÀé¾ë¡¢½»Ã«ÂçÊå¡¢Ã渶²í¹À¡¢¾®ÌîÀîÌ÷Æó¡¢ÊƸ¶½¤Æó¡¢À¾¸¶·½Í´¡¢(»³Ëܹî¸Ê)¡¢(Ê¡Åç²íÇ·)

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Ç´ËìÆ⥷¥å¥ï¥óºÙ˦À­²á¸í¼ð¡Êmucosal Schwann cell hamartoma)¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»¨»ï¡¡109
¥Ú¡¼¥¸ÈÖ¹æ 1776-1783
Ãø¼Ô º´¾å¿¸ÂÀϺ
¶¦Ãø Ê¡Ëܹ¸,¡¡Å·ÌîÈþ½ï,¡¡»³Íº·òÂÀϺ,¡¡¶¶ËܵÁÀ¯,¡¡ÈÓÀ±ÃÎÇî,¡¡¾®ÌîÀîÌ÷Æó,¡¡Ê¿ÌîµðÄÌ,¡¡²ÖÅÄ·É»Î,¡¡Å·Ìî»Ï,¡¡ÆüÌîʸÌÀ,¡¡ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ¼ãǯÀ­Á°Î©Á£´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡65
¥Ú¡¼¥¸ÈÖ¹æ 657-661
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌîÀé¾ë, (º´¾å¿¸ÂÀϺ),¡¡¿¹¹À´õ,¡¡ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë °Û»þÀ­Î¾Â¦À­ÀºÁã¼ðáç¤Î£±Îã -ËÜË®¾ÉÎã¤Î¸¡Æ¤¤Ë²Ã¤¨¤Æ-
»¨»ï¥¿¥¤¥È¥ë ÈçÇ¢´ï²ÊµªÍ× 58
¥Ú¡¼¥¸ÈÖ¹æ 523-526
Ãø¼Ô µÈÌîÀé¾ë
¶¦Ãø ¿¹»³¹ÀÇ·,¡¡ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ¹üÈ×Æâ°­À­·ì´É¼þÈé¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²³°²Ê³Ø²ñ»¨»ï¡¡73
¥Ú¡¼¥¸ÈÖ¹æ 2093-2098
Ãø¼Ô ÅĸýϹÀ
¶¦Ãø Ã渶²í¹À,¡¡½»Ã«ÂçÊå,¡¡ßÀ²¬Æ»Â§,¡¡¹â¶¶¸µ,¡¡ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ¸ÉΩÀ­ç£Å¾°Ü¤ò¤­¤¿¤·¤¿ÍñÁã´â¤Î°ìÎã
»¨»ï¥¿¥¤¥È¥ë »º²Ê¤ÈÉؿͲʡ¡79
¥Ú¡¼¥¸ÈÖ¹æ 1308-1310
Ãø¼Ô Æ£ËܱٻÒ
¶¦Ãø Àî¾åÍβð,¡¡Íê±ÑÈþ,¡¡»°¹¥Çî»Ë,¡¡Ê¡ÅÄÉÒ¾¡,¡¡ÊƸ¶½¤¼£, º´¡¹ÌÚ¹î

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Åö±¡¤Ë¤ª¤±¤ë²È²À­ç¹´â¤Î°ì²È·ÏÎã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡65
¥Ú¡¼¥¸ÈÖ¹æ 532-538
Ãø¼Ô ¾åÌÌï¹á
¶¦Ãø º´¾å¿¸ÂÀϺ,¡¡²ÖÅÄ·É»Î,¡¡ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ·ì´É¹çÊ»ÀÚ½ü¤Ë¤è¤ê´°Á´ÀÚ½ü¤·¤¿¶»Á£´â
»¨»ï¥¿¥¤¥È¥ë ¶»Éô³°²Ê¡¡65
¥Ú¡¼¥¸ÈÖ¹æ 406-409
Ãø¼Ô »³ÌÚ¼Â
¶¦Ãø §¹ÔÉÒÀ¸,¡¡ßÀËÜÀµ¼ù,¡¡ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ¸åÊ¢Ëì¶À²¼¿ÕŦ½ü½Ñ¤Ë¤è¤ë¿ÇÃǤ˻ê¤Ã¤¿¿ÕÊ¿³ê¶Ú¼ð¤Î1Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡65
¥Ú¡¼¥¸ÈÖ¹æ 406-409
Ãø¼Ô µÈÌîÀé¾ë
¶¦Ãø ¿¹»³¹ÀÇ·,¡¡ÊƸ¶½¤¼£,¡¡À¾¸¶·½Í´,¡¡¿¹¹À´õ,¡¡(¼¾å¾Í»Ò)

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Growing¡¡Teratoma¡¡syndrome¤Î°ìÎã
»¨»ï¥¿¥¤¥È¥ë À¾ÆüËÜÈçÇ¢´ï²Ê¡¡74
¥Ú¡¼¥¸ÈÖ¹æ 220-224
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌîÀé¾ë,¡¡ÊƸ¶½¤¼£,¡¡(ÅÄÊÕÅ°¹Ô),¡¡(¿åë²í̦)

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë º¸ÇÙ²½Ç¿¾É¤òȼ¤Ã¤¿À®¿Í¿©Æ»µ¤´Éáñ
»¨»ï¥¿¥¤¥È¥ë ¶»Éô³°²Ê¡¡65
¥Ú¡¼¥¸ÈÖ¹æ 331-334
Ãø¼Ô »³ÌÚ¼Â
¶¦Ãø §¹ÔÉÒÀ¸,¡¡²¼ÅÄÀ¶Èþ,¡¡ÊƸ¶½¤¼£,¡¡(µÝ¾ìÄÌÀµ)

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Æý¤¬¤ó¡¢Ç¾¤ª¤è¤ÓÃæ¿õ¿À·Ð·Ï¼ðáç
»¨»ï¥¿¥¤¥È¥ë ¸¶ÇúÊü¼ÍÀþ¤Î¿ÍÂαƶÁ(Âè2ÈÇ)
¥Ú¡¼¥¸ÈÖ¹æ 132-137¡¢150-156
Ãø¼Ô ÊƸ¶½¤¼£(ʬô¼¹É®)

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ¿Õ´â¤È¤Î´ÕÊ̤¬º¤Æñ¤Ç¤¢¤Ã¤¿¸å¿ÕÀ­Á£¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë À¾ÆüËÜÈçÇ¢´ï²Ê¡¡¡¡74
¥Ú¡¼¥¸ÈÖ¹æ 90-95
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌî´³¾ë, ÊƸ¶½¤¼£, (¹õÅÄľ¿Í)

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Á°Î©Á£¾®ºÙ˦´â¤Î£²Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡¡¡21
¥Ú¡¼¥¸ÈÖ¹æ 41-46
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø µÈÌî´³¾ë, (¶â²¬Î´Ê¿), (ÀС¡¸÷¹­), ÊƸ¶½¤¼£, (»³ÊÕ¹â»Ê), (Ê¡Åç²íÇ·)

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ¹âÎðÃËÀ­¤Ë¤ß¤é¤ì¤¿cecoureterocele¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë À¾ÆüËÜÈçÇ¢´ï²Ê¡¡¡¡73
¥Ú¡¼¥¸ÈÖ¹æ 570-574
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø (¶â²¬Î´Ê¿), (ÀС¡¸÷¹­), ÊƸ¶½¤¼£¡¤(À¥Èø°ì»Ë¡Ë

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ž°ÜÁ㤬¦Â-hCG¤ª¤è¤ÓG-CSF¤ò»ºÀ¸¤·¤Æ¤¤¤¿¤ÈÁÛÄꤵ¤ì¤ë¦Â-hCG»ºÀ¸ç¯æù´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÈçÇ¢´ï³°²Ê¡¡¡¡24
¥Ú¡¼¥¸ÈÖ¹æ 1519-1523
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê¶â²¬Î´Ê¿¡Ë, ¡ÊÀС¡¸÷¹­¡Ë,¡¡ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Àºº÷¼ðáç¤È¤·¤Æȯ¸«¤µ¤ì¤¿°­À­¥ê¥ó¥Ñ¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë À¾ÆüËÜÈçÇ¢´ï²Ê¡¡¡¡73
¥Ú¡¼¥¸ÈÖ¹æ 487-492
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê¶â²¬Î´Ê¿¡Ë, ¡ÊÀС¡¸÷¹­¡Ë,¡¡ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ÇÓÇ¢º¤Æñ¤ò¼çÁʤȤ·¤¿ç¯æùðôÉôÁ°Î©Á£Ãùαǹ˦¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡¡¡64
¥Ú¡¼¥¸ÈÖ¹æ 371-374
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê¶â²¬Î´Ê¿¡Ë, ¡ÊÀС¡¸÷¹­¡Ë,¡¡ÊƸ¶½¤¼£,¡¡¡Ê»ù¶Ì¸÷¿Í¡Ë

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ç¯æù´â¤Èʻ¸¤·¤¿ç¯æùÆâÁ°Î©Á£¥Ý¥ê¡¼¥×¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡¡¡64
¥Ú¡¼¥¸ÈÖ¹æ 319-321
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡ÊËö×¢âðì¡Ë, ¡Ê¶â²¬Î´Ê¿¡Ë, ¡ÊÀС¡¸÷¹­¡Ë, ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ·ÐǢƻŪ¼ê½Ñ¤Ë¤è¤ê´°Á´ÀÚ½ü¤Ç¤­¤¿¤È¹Í¤¨¤é¤ì¤ë¦Â-hCG»ºÀ¸ç¯æù´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡¡¡64
¥Ú¡¼¥¸ÈÖ¹æ 274-277
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê¶â²¬Î´Ê¿¡Ë, ¡ÊÀС¡¸÷¹­¡Ë,¡¡ÊƸ¶½¤¼£,¡¡¡Ê»³ÊÕ¹â»Ê¡Ë

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë çµÁ°ÊɤËȯÀ¸¤·¤¿·ì´É¶ÚÀþ°Ý²êºÙ˦¼ð
»¨»ï¥¿¥¤¥È¥ë Î×¾²ÈçÇ¢´ï²Ê¡¡¡¡65
¥Ú¡¼¥¸ÈÖ¹æ 497-500
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê¶â²¬Î´Ê¿¡Ë, ¡ÊÀС¡¸÷¹­¡Ë,¡¡ÊƸ¶½¤¼£,¡¡Ìܺê°ìÀ®¡¤¡Ê»ù¶Ì¸÷¿Í¡Ë

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Á°Î©Á£ÉôǢƻ¤è¤êȯÀ¸¤·¤¿Àþ°Ý¾åÈéÀ­¥Ý¥ê¡¼¥×
»¨»ï¥¿¥¤¥È¥ë Î×¾²ÈçÇ¢´ï²Ê¡¡¡¡65
¥Ú¡¼¥¸ÈÖ¹æ 493-495
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê¶â²¬Î´Ê¿¡Ë, ¡ÊÀС¡¸÷¹­¡Ë,¡¡ÊƸ¶½¤¼£,¡¡¡ÊÊ¡Åç²íÇ·¡Ë

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ¾®»ùXp11.2/TFE3žºÂ¿Õ´â
»¨»ï¥¿¥¤¥È¥ë Î×¾²ÈçÇ¢´ï²Ê¡¡¡¡65
¥Ú¡¼¥¸ÈÖ¹æ 487-491
Ãø¼Ô ¡ÊÀС¡¸÷¹­¡Ë
¶¦Ãø ¿¹»³¹ÀÇ·, ÊƸ¶½¤¼£,¡¡¡Ê¹õÅÄľ¿Í¡Ë¡¤¡Ê¶â²¬Î´Ê¿¡Ë,¡¡¡Ê»ù¶Ì¸÷¿Í¡Ë

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ç¯æùSpindle Cell Carcinoma¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡¡¡64
¥Ú¡¼¥¸ÈÖ¹æ 241-244
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø (¶â²¬Î´Ê¿), (ÀС¡¸÷¹­), ÊƸ¶½¤¼£, (ÄÚ°æ¡¡·¼¡Ë¡¤¡ÊÇòºêµÁÈÏ¡Ë

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë FDG-PET¤Ë¤ÆºÇ½ªÅª¤Ë°­À­ÉÂÊѤȿÇÃǤµ¤ì¤¿ÇÙ´â¿Õž°Ü¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡¡¡64
¥Ú¡¼¥¸ÈÖ¹æ 210-213
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê³á¸¶¡¡½¼¡Ë¡¤(²­¡¡¿¿¼Â), (¶â²¬Î´Ê¿), (ÀС¡¸÷¹­)¡¤Ìܺê°ìÀ®¡¤¿¹¡¡¹À´õ,ÊƸ¶½¤¼£¡¢É÷ϤÃ潤¡¢(¹­À͵¡Ë¡¤(ÂçÄÍ¿®¾¼)

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ÆýÁ£´É¾õ´â¤ÎÀü»ÉµÛ°úºÙ˦¿Ç¤Î1Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ¹­Å縩»ÙÉô²ñ»ï?32
¥Ú¡¼¥¸ÈÖ¹æ 61-65
Ãø¼Ô ã·Æ£µ×Èþ»Ò
¶¦Ãø ÁêÉôÀ²¹á, ¿ù»³²ÂÂå, ¿ÀÅÄ¿¿µ¬, º´¡¹ÌÚ·ò»Ê, ÊƸ¶½¤¼£, ÁÒÀ¾Ê¸¿Î

!¹¹¿·Æü¡§2013/01/10

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ÆýÁ£¸¶È¯°­À­¥ê¥ó¥Ñ¼ð¤ÎÀü»ÉµÛ°úºÙ˦¿Ç¤Î1Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ¹­Å縩»ÙÉô²ñ»ï?32
¥Ú¡¼¥¸ÈÖ¹æ 29-34
Ãø¼Ô ¿ù»³²ÂÂå
¶¦Ãø ã·Æ£µ×Èþ»Ò, ÁêÉôÀ²¹á, ¿ÀÅÄ¿¿µ¬, º´¡¹ÌÚ·ò»Ê¡¤ ÊƸ¶½¤¼£, ÁÒÀ¾Ê¸¿Î,¾®Àî´îµ±

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë Àü»ÉµÛ°úºÙ˦¿Ç¤Ç¿ÇÃǤ·ÆÀ¤¿ÂñÕÁ£Æ³´É´â¤Î1Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ¹­Å縩»ÙÉô²ñ»ï¡¡31
¥Ú¡¼¥¸ÈÖ¹æ 9·î14Æü
Ãø¼Ô ¿ÀÅÄ¿¿µ¬
¶¦Ãø ã·Æ£µ×Èþ»Ò¡¢ÁêÉôÀ²¹á¡¢¿ù»³²ÂÂå¡¢º´¡¹ÌÚ·ò»Ê¡¢ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë £Â£Ã£Çç¯æùÆâÃíÆþÎÅË¡¸å¤ËȯÀ¸¤·¤¿·ë³ËÀ­ÀºÁã¾åÂαê¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡64
¥Ú¡¼¥¸ÈÖ¹æ 164-166
Ãø¼Ô ¶â²¬Î´Ê¿
¶¦Ãø ¿¹»³¹ÀÇ·, ÀС¡¸÷¹­, ÊƸ¶½¤¼£,¡ÊÊ¡Åç²íÇ·¡Ë

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ÌȱÖÁÈ¿¥³ØŪ¤ËCA 19-9ÍÛÀ­½ê¸«¤òǧ¤á¤¿¿Õ¿»½áÀ­°Ü¹Ô¾åÈé´â¤Î£²Îã
»¨»ï¥¿¥¤¥È¥ë ÈçÇ¢´ï³°²Ê¡¡24
¥Ú¡¼¥¸ÈÖ¹æ 199-204
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¶â²¬Î´Ê¿, ÀС¡¸÷¹­,¡Ê²­¡¡¿¿¼Â¡Ë,¡Ê³á¸¶¡¡½¼¡Ë, ÊƸ¶½¤¼£,¡Ê»ù¶Ì¸÷¿Í¡Ë

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ç¯æùÆâ¤ËȯÀ¸¤·¤¿´¶À÷À­Ç¢Ëì´É¤Î¤¦Ë¦¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡20
¥Ú¡¼¥¸ÈÖ¹æ 41-44
Ãø¼Ô ÀС¡¸÷¹­
¶¦Ãø ¶â²¬Î´Ê¿, ¿¹»³¹ÀÇ·, ¿¹¡¡¹À´õ, ÊƸ¶½¤¼£, ¡ÊÊ¡Åç²íÇ·¡Ë

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ÈóÆðÛÀ­¸Â¶ÉÀ­Ç¢´É±ê¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡20
¥Ú¡¼¥¸ÈÖ¹æ 37-39
Ãø¼Ô ¶â²¬Î´Ê¿
¶¦Ãø ÀС¡¸÷¹­, ¿¹»³¹ÀÇ·, ÊƸ¶½¤¼£¡¢ÌÚÁ¾Å¯»Ê¡¢¿¹¡¡¹À´õ, Ìܺê°ìÀ®

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ½é¿Ç»þ¤è¤êµðÂç¤Ê¸åÊ¢Ëì¥ê¥ó¥ÑÀឰܤòǧ¤á¤¿Á°Î©Á£´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡20
¥Ú¡¼¥¸ÈÖ¹æ 31-35
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¶â²¬Î´Ê¿, ÀС¡¸÷¹­, ÊƸ¶½¤¼£, ÌÚÁ¾Å¯»Ê, ¿¹¡¡¹À´õ, ¡ÊÊ¡Åç²íÇ·¡Ë

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ¸Â¶ÉÀ­Á°Î©Á£´â¤ËÂФ¹¤ëÃѹü¸å¼°½ç¹ÔÀ­Á°Î©Á£Á´Å¦½ü½Ñ¤ÎÉÂÍý³ØŪÀ®ÀÓ
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡63
¥Ú¡¼¥¸ÈÖ¹æ 691-695
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê²­¡¡¿¿¼Â¡Ë, ¡Ê³á¸¶¡¡½¼¡Ë, ¶â²¬Î´Ê¿, ÀС¡¸÷¹­, ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë 17ºÐ½÷À­¤Ë¤ß¤é¤ì¤¿¸åÊ¢Ëì˵¿À·ÐÀá¼ï¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡63
¥Ú¡¼¥¸ÈÖ¹æ 665-669
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¶â²¬Î´Ê¿, ÀС¡¸÷¹­, §¹ÔÉÒÀ¸, ¡ÊÀк깯Âå¡Ë, À¥Ï²Àµ¼ù, ¿¹Ëܸ¬°ì, ËÙ¡¡°ê»Ò, ÊƸ¶½¤¼£, Ìܺê°ìÀ®, ¡Ê¾¾¸¶¸­¼£¡Ë

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ðùγµå¥³¥í¥Ë¡¼»É·ã°ø»Ò¡ÊG-CSF¡Ë»ºÀ¸ç¯æù´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë À¾ÆüËÜÈçÇ¢´ï²Ê¡¡72
¥Ú¡¼¥¸ÈÖ¹æ 475-479
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¶â²¬Î´Ê¿, ÀС¡¸÷¹­, ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ¸åÊ¢Ëì¶À²¼¿ÕŦ½ü½Ñ¤¬²Äǽ¤Ç¤¢¤Ã¤¿½ÅÊ£²¼ÂçÀÅÌ®¤òȼ¤¦º¸¿ÕºÙ˦´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡63
¥Ú¡¼¥¸ÈÖ¹æ 531-534
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¶â²¬Î´Ê¿, ÀС¡¸÷¹­, Ìܺê°ìÀ®, ÊƸ¶½¤¼£, ¡Ê»³ÊÕ¹â»Ê¡Ë

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ²«¿§Æù²ê¼ðÀ­¿Õ⳿ձê¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡63
¥Ú¡¼¥¸ÈÖ¹æ 463-465
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê²­¡¡¿¿¼Â¡Ë¡¤ ¡Ê³á¸¶¡¡½¼¡Ë¡¤ ¶â²¬Î´Ê¿¡¤ ÀС¡¸÷¹­¡¤ ¾¡Ã«¾»Ê¿¡¤ ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë TURBT¤Ë¤è¤ê¿ÇÃǤµ¤ì¤¿¦Â-hCG»ºÀ¸ç¯æù¼ðáç
»¨»ï¥¿¥¤¥È¥ë Î×¾²ÈçÇ¢´ï²Ê¡¡64
¥Ú¡¼¥¸ÈÖ¹æ 597-600
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ÊƸ¶½¤¼£, ¶â²¬Î´Ê¿, ÀС¡¸÷¹­, ¹âß·¿®¹¥, ¿¹¡¡¹À´õ

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ±¢Ç¹Æâ»éËüð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡63
¥Ú¡¼¥¸ÈÖ¹æ 395-397
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê²­¡¡¿¿¼Â¡Ë, ¡Ê³á¸¶¡¡½¼¡Ë, ¶â²¬Î´Ê¿, ÀС¡¸÷¹­, ÊƸ¶½¤¼£, ¿¹¡¡¹À´õ, ¡Ê»ù¶Ì¸÷¿Í¡Ë

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ÉÂÍý¸¦µæ¸¡ºº²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ¥¹¥Ë¥Á¥Ë¥ÖÆâÉþÃæ¤Ë½Ð¸½¤·¤¿¾Ã²½´ÉÀü¹¦¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÈçÇ¢´ï³°²Ê¡¡23
¥Ú¡¼¥¸ÈÖ¹æ 623-627
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡Ê²­¡¡¿¿¼Â¡Ë, ÀС¡¸÷¹­, Ê¿ÌîµðÄÌ, ¡Ê»³Æâ¿ò¹¨¡Ë, Ã渶²í¹À, ßÀ²¬Æ»Â§, ¡Ê¿·ÄŹ¨ÌÀ¡Ë, ÊƸ¶½¤¼£
µá¿Í¾ðÊó¤Î¤ªÃΤ餻 Åö±¡¤Ï(ºâ)ÆüËÜ°åÎÅɾ²Áµ¡¹½¤Ë¤è¤ëǧÄê¤ò¼õ¤±¤Æ¤¤¤Þ¤¹¡£

JAÈøÆ»Áí¹çɱ¡Î×¾²²Ê¤Î¥Õ¥§¥¤¥¹¥Ö¥Ã¥¯ Î×¾²²Ê

JAÈøÆ»Áí¹çɱ¡Î×¾²¸¦½¤²Ê¤Î¥Õ¥§¥¤¥¹¥Ö¥Ã¥¯ Î×¾²¸¦½¤²Ê

JAÈøÆ»Áí¹çɱ¡ »Ô̱¸ø³«¹ÖºÂ »Ô̱¤Î¤¿¤á¤Î¤¬¤óºÇÁ°Àþ

JAÈøÆ»Áí¹çɱ¡ ÇÛ¿®Æ°²è°ìÍ÷

 
¥Ú¡¼¥¸ÀèƬ¤ØÌá¤ë